Advertisement

Topics

"Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis" Drugs and Medication Database

13:30 EDT 14th August 2018 | BioPortfolio

Here are the most relevant "Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis" Drugs and Medications that we have found in our database.

More Information about "Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis" on BioPortfolio

We have published hundreds of Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis news stories on BioPortfolio along with dozens of Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis Clinical Trials and PubMed Articles about Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis Companies in our database. You can also find out about relevant Safety and Efficacy Extension Study of Daclizumab HYP to Treat Relapsing-Remitting Multiple Sclerosis Drugs and Medications on this site too.

Showing "Safety Efficacy Extension Study Daclizumab Treat Relapsing Remitting" Drugs and Medications 1–25 of 171

Probably Relevant

Rebif [EMD Serono, Inc.]

Rebif (interferon beta-1a)

Betaseron [Bayer HealthCare Pharmaceuticals Inc.]

BETASERON(Interferon beta-lb)

Leflunomide [NorthStar RxLLC]

Leflunomide Tablets USP

Possibly Relevant

Life extension sun protection spf 30 [LifeExtension Foundation]

Life Extension Sun Protection Spray With Beta Glucan SPF 30

Mitoxantrone [APP Pharmaceuticals, LLC]

Mitoxantrone Injection, USP

Tacrolimus [Dr. Reddy's Laboratories Limited]

Tacrolimus Capsules

Tacrolimus [American Health Packaging]

Tacrolimus Capsules, 0.5mg, 1mg, 5mg

Tacrolimus [Accord Heathcare, Inc.]

Tacrolimus Capsules

Mitoxantrone [Hospira Worldwide, Inc.]

MitoXANTRONE Injection, USP

Mitoxantrone [Teva Parenteral Medicines, Inc]

mitoXANTRONE Injection USP (concentrate)

Doryx [Warner Chilcott (US), LLC]

These highlights do not include all the information needed to use DORYX (Doxycycline Hyclate Delayed-Release Tablets, USP) safely and effectively. See Full Prescribing Information for DORYX Tablets. DORYX (Doxycycline Hyclate Delayed-Release Tablet

Doxycycline hyclate [Global Pharmaceuticals, Division of Impax Laboratories Inc.]

These highlights do not include all the information needed to use doxycycline hyclate delayed-release tablets, USP safely and effectively. See Full Prescribing Information for doxycycline hyclate delayed-release tablets, USP. Doxycycline Hyclate Delayed

Tysabri [Elan Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection for intravenous useInitial U.S. Approval: 2004

Copaxone [Teva Neuroscience, Inc.]

These highlights do not include all the information needed to use COPAXONE safely and effectively. See full prescribing information for COPAXONE. COPAXONE (glatiramer acetate) injection, solution for subcutaneous useInitial U.S. Approval: 1996

Carisoprodol [Unit Dose Services]

These highlights do not include all the information needed to use carisoprodol safely and effectively. See full prescribing information for carisoprodol tablets. Carisoprodol Tablets, USP for Oral use Initial U.S. Approval: 1959

Tacrolimus [UDL Laboratories, Inc.]

Tacrolimus [Mylan Pharmaceuticals Inc.]

Carisoprodol [Sun Pharmaceutical Industries Limited ]

These highlights do not include all the information needed to use carisoprodol safely and effectively. See full prescribing information for carisoprodol tablets. Carisoprodol Tablets, USP for Oral use Initial U.S. Approval: 1959

Gilenya [Novartis Pharmaceuticals Corporation]

These highlights do not include all the information needed to use   GILENYA  safely and effectively.   See full prescribing information for   GILENYA. GILENYA

Gelnique [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use GELNIQUE safely and effectively.See full prescribing information for GELNIQUE. GELNIQUE (oxybutynin chloride) gel for topical useInitial U.S. Approval: 1975

Hipoglos [Laboratorios Andromaco S.A.]

Hipoglós Ointment

Zonisamide [STAT RX USA LLC]

Sucralfate [Levista, Inc.]

Sucralfate Tablets, USP

Carisoprodol [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use carisoprodol safely and effectively. See full prescribing information for carisoprodol.Carisoprodol Tablets, USP for Oral useInitial U.S. Approval: 1959

Sucralfate [Nostrum Laboratories, Inc.]

Sucralfate Tablets, USP



Advertisement
Quick Search
Advertisement
Advertisement